Clinical Trial Update: Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD) [NA]

View source ↗

Summary

Clinical trial update reports that fucoidan may improve metabolic profiles in patients with non-alcoholic fatty liver disease (NAFLD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Fucoidan (fucoidan)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Non-alcoholic Fatty Liver Disease | NA | Status: COMPLETED | Results posted: 2021-03-17